Shares of CME Group Inc (NASDAQ:CME) have been assigned a consensus rating of “Buy” from the seventeen analysts that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $157.25.
Several brokerages have weighed in on CME. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 6th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research note on Tuesday, January 2nd. Berenberg Bank began coverage on shares of CME Group in a research note on Thursday, January 25th. They set a “hold” rating and a $170.00 target price for the company. Citigroup reaffirmed a “buy” rating and set a $172.00 target price (up previously from $155.00) on shares of CME Group in a research note on Monday, January 29th. Finally, Sandler O’Neill reaffirmed a “buy” rating and set a $175.00 target price on shares of CME Group in a research note on Friday, February 2nd.
In other news, CFO John W. Pietrowicz sold 7,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $151.50, for a total value of $1,136,250.00. Following the completion of the transaction, the chief financial officer now owns 32,376 shares of the company’s stock, valued at $4,904,964. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Jack J. Tobin sold 2,325 shares of the firm’s stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $152.28, for a total transaction of $354,051.00. Following the completion of the transaction, the insider now directly owns 17,574 shares of the company’s stock, valued at approximately $2,676,168.72. The disclosure for this sale can be found here. In the last three months, insiders sold 43,024 shares of company stock valued at $6,620,113. Insiders own 0.57% of the company’s stock.
Shares of CME Group (NASDAQ CME) traded up $2.98 on Friday, hitting $171.42. 1,942,883 shares of the company were exchanged, compared to its average volume of 1,900,000. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03. CME Group has a 12-month low of $114.82 and a 12-month high of $171.71. The stock has a market capitalization of $58,350.00, a price-to-earnings ratio of 39.87, a P/E/G ratio of 2.20 and a beta of 0.54.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm had revenue of $900.00 million during the quarter, compared to analyst estimates of $886.85 million. During the same quarter in the prior year, the firm posted $1.14 earnings per share. CME Group’s quarterly revenue was down 1.4% on a year-over-year basis. equities analysts anticipate that CME Group will post 6.47 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be paid a $0.70 dividend. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $2.80 annualized dividend and a dividend yield of 1.63%. CME Group’s dividend payout ratio (DPR) is presently 65.12%.
TRADEMARK VIOLATION WARNING: “CME Group Inc (CME) Receives Average Recommendation of “Buy” from Analysts” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/3255432/cme-group-inc-cme-receives-average-recommendation-of-buy-from-analysts.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.